Objectives

After participating in this educational activity, attendees should be able to:
1| Recognize the risk of low bone density in patients receiving treatment for breast cancer.
2| Identify patients who meet criteria for medical management.
3| To review options for medical management to optimize bone health in patients with breast cancer receiving aromatase inhibitors
4|Review effect of estrogen on bone and effect of tamoxifen and AI on bone health.
5|Effect of bisphosphonates and denosumab on breast cancer independent of bone health.


Presenter(s): 

Parvathy Madhavan, MD
Assistant Professor of Medicine
Director, Bone health clinic, Neag Comprehensive Cancer Center
Division of Endocrinology and Metabolism 
UCONN HEALTH | UCONN School of Medicine 

 

NameRoleFinancial Relationship DisclosuresDiscussion of
Unlabeled/Unapproved Uses of
Drugs/Devices in Presentation?
Parvathy Madhavan, MD SpeakerNo relevant relationships with ineligible companies to discloseNo

 

Session date: 
12/02/2025 - 12:00pm to 1:00pm EST
Location: 
Webinar
United States
See map: Google Maps
Add to calendar: 
  • 1.00 AAPA Category 1 CME credit
    Baystate Health has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 1.00 AAPA Category 1 CME credits. PA’s should only claim credit commensurate with the extent of their participation.
  • 1.00 ACPE Contact Hours
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 IPCE Credit Hour(s)
Please login or register to take this course.